SAPS-025 - Psoriasis patients’ perceptions of biosimilars and associated factors

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: SAPS-025
• By: LINDEN, Kari
• Co-author(s): BSc Pharm student Martta Räsänen (University of Helsinki, Helsinki, Finland)
  Dr Maarit Dimitrow (University of Helsinki, Helsinki, Finland)
  Dr Marika Pohjanoksa-Mäntylä (University of Helsinki, Helsinki, Finland)
  Dr Santtu Mikkonen (University of Eastern Finland, Kuopio, Finland)
  Professor Marja Airaksinen (University of Helsinki, Helsinki, Finland)
  Dr Kari Linden (University Pharmacy (YA), Helsinki, Finland)
  
• Abstract:

  Introduction:
  Biological medicines have a significant role in treating psoriasis. Biosimilars are interchangeable and highly similar to their original (reference) products containing the same active pharmaceutical ingredient. Biosimilars are often more affordable, and they are increasingly prescribed or switched by physicians or substituted by..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login